Efficacy of Psychological Intervention for Children With Cancer
1 other identifier
interventional
80
1 country
1
Brief Summary
The study will be conductued at the Pediatric Oncology Department of the Children's Hospital, PIMS Islamabad, over the peroid of six months. This single-blinded, two-arm RCT study will involve 80 children aged 8 to 16 years with maligancies recieving chemotherapy. Participants will be randomly allocated to either interventional or CBT group which will recieve weekly five sessions of Cognitive Behaviour Therapy (CBT) or the control group, which will recieve the usual care. CBT session will be contducted by Clinical Psychologist will last 30-35 minutes. Outcomes will be measured at Baseine and one month post intervention using Revised Child Anxiety and Depression Scale (RCADS) and Pediatric Quality of Life Generic Core Score 4.0.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2024
CompletedFirst Posted
Study publicly available on registry
October 1, 2024
CompletedStudy Start
First participant enrolled
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedOctober 1, 2024
September 1, 2024
4 months
September 10, 2024
September 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Revised Child Anxiety and Depression Scale (RCADS)
The RCADS is a standardized, self reported scale measuring anxiety and depression symptoms among children aged 8-18 years.
Baseline (before the intervention) and one month post intervention (after the five weekly sessions of CBT)
Secondary Outcomes (1)
Pediatric QoL
Baseline and one month post intervention
Study Arms (2)
Interventional Group
EXPERIMENTALThe Intervention or CBT group included 40 children aged 8-16 years with malignancies recieving chemotherapy. They will recieve weekly five sessions of CBT (30-35 minutes per session)
Control or Usual Care Group
NO INTERVENTIONThe Control or No Intervention Group also known as Comparision Group or Usual Group will recieve the standard care or usual care for their condition. It will serve as a baseline for the CBT or Intervention Group.
Interventions
This RCT aims to evaluate the effect of Cognitive Behavioral Therapy (CBT) compared to usual care (UC) in pediatric oncology patients. We hypothesize that those receiving CBT will report lower depression and anxiety and improved QoL six months post-enrollment.
Eligibility Criteria
You may qualify if:
- Children aged 16-18 years
- Diagnosed with malignancy
- Recieving chemotherapy at the Pediatric Oncology Department of PIMS Islamabad
- Able to understand and participate in CBT sessions
- Parent/Caregiver consent and child assent
- Exlusion Criteria:
- Children with severe cognitive impairment or intellectual disability
- Children with a comorbid medical conditions
- Children whose parents or caregivers are unable to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Muhammad Wasim Khan
Islamabad, 44000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants (Children/Guaddians or Parents) are unaware of which group they are assigned (CBT group or usual care group). Researcher are aware of the group assignments.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Muhammad Wasim Khan
Study Record Dates
First Submitted
September 10, 2024
First Posted
October 1, 2024
Study Start
October 10, 2024
Primary Completion
February 10, 2025
Study Completion
June 30, 2025
Last Updated
October 1, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
Demographic, Clinical and Treatment related Information of the Participants